iCo Therapeutics (Canada)

TCR Activation Inhibits Chemotaxis Toward Stromal Cell-Derived Factor-1: Evidence for Reciprocal Regulation Between CXCR4 and the TCR

James W. Peacock, Frank R. Jirik · The Journal of Immunology · 1999 · 103 citations · Full text

Inflammation, Sdf-1 Treatment, Cytokine +15

Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis

Kishor M. Wasan, Ellen K. Wasan, Pavel Gershkovich et al. · The Journal of Infectious Diseases · 2009 · 86 citations

Pharmaceutical Science, Murine Visceral Leishmaniasis, Antiparasitic Agent +13

Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues

Nisha Chander, Genc Basha, Miffy H. Y. Cheng et al. · Molecular Therapy — Methods & Clinical Development · 2023 · 85 citations · Full text

Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation

Pavel Gershkovich, Ellen K. Wasan, M. Lin et al. · Journal of Antimicrobial Chemotherapy · 2009 · 79 citations

Mechanism of Action and Limited Cross-Resistance of New Lipopeptide MX-2401

Evelina Rubinchik, Tanja Schneider, Melissa Elliott et al. · Antimicrobial Agents and Chemotherapy · 2011 · 76 citations · Full text